Bahram Mofid

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Topics

Prostate Cancer

Diffuse Large B Cell Lymphoma

Peritoneal Dialysis

Top Venues

International journal of radiation biology

Phytotherapy research : PTR

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Ali Mahdavi, Bahram Mofid, Farzad Taghizadeh-Hesary
Intra-prostatic gold fiducial marker insertion for image-guided radiotherapy (IGRT): five-year experience on 795 patients. BMC medical imaging 23 (1) (2023)
Saman Moradi, Bijan Hashemi, Mohsen Bakhshandeh, Amin Banaei, Bahram Mofid
Introducing new plan evaluation indices for prostate dose painting IMRT plans based on apparent diffusion coefficient images. Radiation oncology (London, England) 17 (1) (2022)
Abolfazl Razzaghdoust, Mahdi Ghajari, Abbas Basiri, Peyman Mohammadi Torbati, Anya Jafari, Mohammad Reza Fattahi, Maryam Salahi, Bahram Mofid
Association of immunohistochemical markers of tumor subtype with response to neoadjuvant chemotherapy and survival in patients with muscle-invasive bladder cancer. Investigative and clinical urology 62 (3) (2022)
Abolfazl Razzaghdoust, Shahabedin Rahmatizadeh, Bahram Mofid, Samad Muhammadnejad, Mahmoud Parvin, Peyman Mohammadi Torbati, Abbas Basiri
Data-Driven Discovery of Molecular Targets for Antibody-Drug Conjugates in Cancer Treatment. BioMed research international 2021 (2021)
Abolfazl Razzaghdoust, Bahram Mofid, Parvin Peyghambarlou
Predictors of chemotherapy-induced severe anemia in cancer patients receiving chemotherapy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 28 (1) (2019)
Abolfazl Razzaghdoust, Bahram Mofid, Masoumeh Zangeneh
Predicting chemotherapy-induced thrombocytopenia in cancer patients with solid tumors or lymphoma. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (3) (2019)
Afshin Saadipoor, Abolfazl Razzaghdoust, Nasser Simforoosh, Arash Mahdavi, Mohsen Bakhshandeh, Maryam Moghadam, Hamid Abdollahi, Bahram Mofid
Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy. Phytotherapy research : PTR 33 (2) (2018)
Hamid Abdollahi, Seied Rabi Mahdavi, Bahram Mofid, Mohsen Bakhshandeh, Abolfazl Razzaghdoust, Afshin Saadipoor, Kiarash Tanha
Rectal wall MRI radiomics in prostate cancer patients: prediction of and correlation with early rectal toxicity. International journal of radiation biology 94 (9) (2018)